HAI Diagnostic and Testing Markets Show 3 Percent Growth

Article

A new market research report from Kalorama Information, "Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends," says that diagnostics and treatment segments taken together are valued at more than $9 billion for 2010 with 2015 sales expected to reach $10.3 billion.

The market has grown by 3 percent year-on-year, with sales increasing from $7.9 billion in 2005. With the treatment segment struggling to maintain growth, the testing segment is likely to offset declines starting in 2012.

Recent Videos
Mark Wiencek, PhD
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Physicians Sound Alarm: Vaccine Misinformation and Policy Failures Threaten US Public Health
Lucy Witt, MD
Vatsala Rangachar Srinivasa, MPH
Damien Berg, BA, BS, CRCST, AAMIF, is the vice president of strategic initiatives for the HSPA.
Related Content